Invention for Innovation - Challenge Awards Committee
Contents
The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has four committees: two for Product Development Awards (committee A and committee B), one for Challenge Awards, and one for Connect.
Committee members - Challenge Awards
| Name | Position | Organisation | Expertise |
|---|---|---|---|
| Professor Nick Lemoine (Chair) | Director | Barts Cancer Institute | Professor Lemoine is the Director of Barts Cancer Institute. His groups' primary research interests are in the genomics and molecular pathology of pancreatic cancer and the development of oncolytic virotherapy. |
| Ms Jo Smart (Deputy Chair) | Chief Operating Officer | VivoPlex Medical Ltd | Ms Smart is a life sciences business executive with over 15 years' experience, and is COO of Vivoplex Medical Ltd, a UK medtech SME. |
| Mrs Janet Champion | Public Committee Member | PPI Representative | PPI Representative |
| Mr Chris Chaney | Chief Executive | Chelsea and Westminster Hospitals NHS Foundation Trust | Mr Chaney leads the innovation programme at Chelsea and Westminster Hospital Foundation Trust, is a member of the Trust Board and CEO of Trust charity, CW+ |
| Dr Iain Hennessey | Clinical Director of Innovation | Alder Hay Children’s NHS Foundation Trust | Dr Hennessey is involved in paediatric surgery, surgical simulation and clinical innovation. |
| Professor Claire Hulme | Professor of Health Economics | Institute of Health Research, University of Exeter | Professor Hulme is a health economist whose background lies in range of methodologies including economic evaluation, large data analysis and use of qualitative methods in health economics. |
| Mrs Ceila Ingham-Clark | Medical Director for Clinical Effectiveness | NHS England | Mrs Clark is a Medical Director for Professional Leadership and Clinical Effectiveness; previous Trust Medical Director and general surgeon. |
| Dr Zarnie Khadjesari | Senior Lecturer in Health Promotion | University of East Anglia | Dr Khadjesari is an implementation scientist and digital health researcher in the field of health promotion. She is experienced in both quantitative and qualitative research methods. |
| Mrs Anna King | Commercial Director | South London Academic Health Science Network (AHSN) | Mrs King has financial, commercial and business experience across a wide range of pharmaceutical and healthcare areas, including digital |
| Dr David Kryl | Director of Insight for Wessex AHSN | Wessex Academic Health Science Network (AHSN) | Dr Kryl is responsible for the evaluation strategy of Wessex Academic Health Science Network, with expertise in implementation, research, evaluation, and impact assessment frameworks |
| Dr Sarah Markham | Public Committee Member | PPI Representative | PPI Representative |
| Miss Fay McCracken | Associate Director | NICE Office for Market Access Accelerated Access Collaborative Secretariat | Miss McCracken has over 15 years’ experience in Health Technology Assessment, health economics and market access for all types of life sciences products |
| Mr Stuart Mealing | Associate Director for Health Technology Assessment | York Health Economics Consortium Ltd | Mr Mealing has a range of experience in decision analytic modelling, statistical analysis of patient level data (from clinical trials to large real world evidence datasets), Preparation of health technology assessment submission dossiers |
| Mr Steve Morris | CEO | Creo Medical | Mr Morris has over 15 years of experience managing complex projects and programmes in the Defence sector. He has led project teams for the Ministry of Defence, and delivering major projects for the Royal Navy and the British Army. Mr. Morris holds a BScEng and is a member of the IET and the Association for Project Management |
| Mr Sebastian Orton | Partner, Corporate | Penningtons Manches LLP | Mr Orton is a corporate finance lawyer with specific expertise in equity capital markets and raising finance for companies in the life sciences sector |
| Professor Amar Rangan | Professor of Orthopaedic Surgery | Universities of York and Oxford | Professor Rangan is a specialist shoulder & elbow surgeon; Experienced in clinical effectiveness and translational research |
| Mr Simon Thorn | Managing Director | Acceleris Capital Limited | Mr Thorn is experienced in evaluating the financial, corporate and commercial aspects of early stage healthcare propositions from a business viability and investability angle |
| Professor Wendy Tindale | Director | NIHR Devices for Dignity MIC | Professor Tindale is involved in Test Beds and experienced in implementation of MedTech |